Similar articles

• Serum immunoreactive collagen IV detected by monoclonal antibodies as a marker of severe fibrosis in patients with non-alcoholic fatty liver disease.

  Aida Y, Abe H, Tomita Y, Nagano T, Seki N, Sugita T, Itagaki M, Ishiguro H, Sutoh S, Aizawa Y. Aida Y, et al. J Gastrointestin Liver Dis. 2015 Mar;24(1):61-8. doi: 10.15403/jgld.2014.1121.yad. J Gastrointestin Liver Dis. 2015. PMID: 25822435
• Nonalcoholic fatty liver disease and hepatic cirrhosis: Comparison with viral hepatitis-associated steatosis.

  Haga Y, Kanda T, Sasaki R, Nakamura M, Nakamoto S, Yokosuka O. Haga Y, et al. World J Gastroenterol. 2015 Dec 14;21(46):12989-95. doi: 10.3748/wjg.v21.i46.12989. World J Gastroenterol. 2015. PMID: 26675364 Free PMC article. Review.
• Altered Peripheral Blood Monocyte Phenotype and Function in Chronic Liver Disease: Implications for Hepatic Recruitment and Systemic Inflammation.

  Gadd VL, Patel PJ, Jose S, Horsfall L, Powell EE, Irvine KM. Gadd VL, et al. PLoS One. 2016 Jun 16;11(6):e0157771. doi: 10.1371/journal.pone.0157771. eCollection 2016. PLoS One. 2016. PMID: 27309850 Free PMC article.
• Clinical importance of the nonalcoholic fatty liver disease: a review.

  Chumak AA, Ovsyannikova LM, Sarkisova EA, Gasanova EV. Chumak AA, et al. Probl Radiac Med Radiobiol. 2013;(18):277-88. Probl Radiac Med Radiobiol. 2013. PMID: 25191732 Review. English, Ukrainian.
• Testing for Nonalcoholic Fatty Liver Disease.

  Juo YY, Livingston EH. Juo YY, et al. JAMA. 2019 Nov 12;322(18):1836. doi: 10.1001/jama.2019.10696. JAMA. 2019. PMID: 31714988 No abstract available.